lorazepam has been researched along with acetaminophen in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.86) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 16 (57.14) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blyden, GT; Greenblatt, DJ; Scavone, JM | 1 |
| Engelking, LR; Greenblatt, DJ | 1 |
| Abernethy, DR; Ameer, B; Greenblatt, DJ; Shader, RI | 1 |
| Abernethy, DR; Divoll, M; Greenblatt, DJ; Shader, RI | 1 |
| Abernethy, DR; Ameer, B; Divoll, M; Greenblatt, DJ; Shader, RI | 1 |
| Greenblatt, DJ; Harmatz, JS; Manis, M; Poorman, R; von Moltke, LL | 1 |
| Clifford, TJ; Neto, GM; Plint, A; Randhawa, N; Reid, SM | 1 |
| Collins, CH; Collins, KE; Faria, AM | 1 |
| Bird, S; Cohen, J; Ganetsky, M; Kent, K | 1 |
| Khan, KH; Tham, TC | 1 |
| Bayerl, MG; Claxton, DF; Liao, J; Talamo, G; Zangari, M | 1 |
| Akhileswaran, R; Heng, CP; Hui, D; Tan, A; Yap, R | 1 |
| Alsubih, M; Balakrishnan, D; El Morabet, R; Khan, AR; Khan, NA; Khan, RA; Khan, S; Khoo, KS; Mubashir, M | 1 |
3 review(s) available for lorazepam and acetaminophen
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lorazepam and acetaminophen
| Article | Year |
|---|---|
Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy.
Topics: Acetaminophen; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics; Anesthesia, Local; Anti-Anxiety Agents; Biopsy, Needle; Bone Marrow; Female; Humans; Lorazepam; Male; Middle Aged; Oxycodone; Pain; Pain Measurement | 2010 |
24 other study(ies) available for lorazepam and acetaminophen
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam.
Topics: Acetaminophen; Adult; Alprazolam; Antipyrine; Drug Administration Schedule; Drug Interactions; Female; Humans; Influenza Vaccines; Lorazepam; Male; Middle Aged; Time Factors | 1989 |
Enterohepatic circulation of lorazepam and acetaminophen conjugates in ponies.
Topics: Acetaminophen; Animals; Bile; Enterohepatic Circulation; Female; Glucuronates; Half-Life; Horses; In Vitro Techniques; Lorazepam; Sulfates | 1988 |
Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
Topics: Acetaminophen; Adult; Drug Interactions; Female; Glucuronates; Humans; Lorazepam; Male; Metabolic Clearance Rate; Middle Aged; Probenecid | 1985 |
Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
Topics: Acetaminophen; Adult; Aged; Anti-Anxiety Agents; Female; Glucuronates; Humans; Lorazepam; Male; Middle Aged; Obesity; Oxazepam | 1983 |
Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.
Topics: Acetaminophen; Adult; Animals; Antipyrine; Biotransformation; Cimetidine; Diazepam; Guanidines; Humans; Kinetics; Lethal Dose 50; Lorazepam; Male; Mice; Oxidation-Reduction | 1983 |
Inhibition of acetaminophen and lorazepam glucuronidation in vitro by probenecid.
Topics: Acetaminophen; Animals; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; In Vitro Techniques; Lorazepam; Macaca; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Probenecid; Rats; Rats, Sprague-Dawley | 1993 |
Use of single-dose activated charcoal among Canadian pediatric emergency physicians.
Topics: Acetaminophen; Adolescent; Antidotes; Canada; Charcoal; Child, Preschool; Cross-Sectional Studies; Digoxin; Emergency Service, Hospital; Guideline Adherence; Health Care Surveys; Humans; Ibuprofen; Iron Compounds; Lorazepam; Male; Paroxetine; Poisoning; Time Factors | 2006 |
Preparation and characterization of poly(methyltetradecylsiloxane) stationary phases immobilized by gamma radiation onto zirconized silica.
Topics: Acetaminophen; Alprazolam; Benzene Derivatives; Chromatography, High Pressure Liquid; Ibuprofen; Lorazepam; Magnetic Resonance Spectroscopy; Silicon Dioxide; Siloxanes; Spectrophotometry, Infrared; Uracil; Zirconium | 2007 |
Non-fatal ventricular dysrhythmias associated with severe salicylate toxicity.
Topics: Acetaminophen; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Aspirin; Female; Hemofiltration; Humans; Lorazepam; Middle Aged; Suicide, Attempted; Treatment Outcome; Ventricular Dysfunction | 2008 |
Neuroleptic malignant syndrome induced by quetiapine overdose.
Topics: Acetaminophen; Antidotes; Antipsychotic Agents; Dibenzothiazepines; Drug Overdose; Female; Humans; Lorazepam; Middle Aged; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Treatment Outcome | 2008 |
Comfort care kit: use of nonoral and nonparenteral rescue medications at home for terminally ill patients with swallowing difficulty.
Topics: Acetaminophen; Adjuvants, Anesthesia; Administration, Rectal; Administration, Sublingual; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Antipsychotic Agents; Atropine; Caregivers; Deglutition Disorders; Female; Haloperidol; Home Care Services; Humans; Lorazepam; Male; Middle Aged; Morphine; Palliative Care; Pilot Projects; Singapore; Terminally Ill | 2014 |
Comparison of constructed wetland performance coupled with aeration and tubesettler for pharmaceutical compound removal from hospital wastewater.
Topics: Acetaminophen; Animals; Carbamazepine; Ciprofloxacin; Erythromycin; Hospitals; Ibuprofen; Lorazepam; Pharmaceutical Preparations; Simvastatin; Waste Disposal, Fluid; Wastewater; Wetlands | 2023 |